President Trump Announces Pfizer $70 Billion Deal to Lower Prescription Drug Costs

On Tuesday, President Trump announced a $70 billion agreement with Pfizer to bring production back to the US and reduce the cost of prescription drugs. Pfizer will reshore key production sites and sell drugs at "most favored nation" pricing, which is comparable to what other nations pay. For American patients: a $70 billion deal with Pfizer that will bring significant pharmaceutical production back home and reduce the cost of prescription medications.
According to Trump, the agreement represents a major victory in his Make America Healthy Again campaign and carries out his promise to "end global price gouging at the expense of American families." "A historic day," according to Pfizer CEO Albert Bourla, the deal ends years of unfair pricing in which American patients "assumed disproportionate costs" in comparison to those in other wealthy countries.